Skopos Labs, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $225 Million
- Q2 2024
A detailed history of Skopos Labs, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 484 shares of REGN stock, worth $399,048. This represents 0.23% of its overall portfolio holdings.
Number of Shares
484
Previous 484
-0.0%
Holding current value
$399,048
Previous $469 Million
99.89%
% of portfolio
0.23%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,492Shares Held
85.8MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$7.42 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.96 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$6.17 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.84MShares$3.99 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$3.82 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $88.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...